Vivoryon Therapeutics NV (VVY) — Cash Flow Quality Index

Latest as of September 2021: -0.18x

Vivoryon Therapeutics NV (VVY) has a Cash Flow Quality Index of -0.18x as of September 2021. Operating cash flow of €-796.00K is below net income of €4.41 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Vivoryon Therapeutics NV total assets for the complete picture of this company's asset base.

Cash Flow Quality Index

-0.18x

Operating CF / Net Income

Operating Cash Flow

€-796.00K

EUR

Net Income

€4.41 Million

EUR

Data as of

Sep 2021

Most recent filing

Annual Cash Flow Quality Index for Vivoryon Therapeutics NV (None–None)

Year-by-year earnings quality comparison for Vivoryon Therapeutics NV. For live market cap and the full company financial profile, see VVY stock market capitalisation.

Year	Quality Index	Operating CF (EUR)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.